avelumab,eculizumab,olaparib,iptacopan,Ravulizumab
merck,alexion pharmaceuticals,astrazeneca,pfizer,novartis
['dance', ' ola ', 'eculizumab', ' ave ']
exciting data just presented by r gis peffault de latour at #ash22 shows iptacopan, an oral proximal complement inhibitor, very effective in #pnh patients with suboptimal response to c5 inhibitors. #bmfsm 
???????????Haematologist @nih_nhlbi l via  @ucdmedicine @trinitymed1 l Lover of ????????l #SAA #IBMFS #telomeres #CHIP #MDS #AML #HSCT #VEXAS l Comments mine.